Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





DIISOBUTYL KETONE								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 108-83-8; **Chemical Formula:** [(CH3)2CHCH2]2CO
OSHA previously had an 8-hour limit of 50 ppm TWA for diisobutyl ketone. The Agency proposed to reduce this limit to 25 ppm TWA, based on both the ACGIH and NIOSH recommendations. NIOSH (Ex. 8-47, Table N1) concurred with this proposal, and the final rule revises OSHA’s limit for diisobutyl ketone to 25 ppm as an 8-hour time-weighted average.
The primary health effects associated with exposure to diisobutyl ketone are eye, nose, and throat irritation, although experimental animals have shown some systemic effects. Diisobutyl ketone has a uniformly low acute toxicity by all routes of exposure. Rats and guinea pigs survived single exposures of from 7.5 to 16 hours to essentially saturated vapor (McOmie and Anderson 1949/Ex. 1-918). Smyth, Carpenter, and Weil (1949/Ex. 1-528) reported that five of six rats died after exposure to 2000 ppm for eight hours; these investigators also reported a percutaneous LD(50) for rabbits of greater than 20 ml/kg. Direct application of diisobutyl ketone to rabbit skin was only mildly irritating, and no eye irritation was reported after instillation of this substance into the rabbit eye. The oral toxicity for the rat was reported as 5.8 g/kg (Smyth, Carpenter, and Weil 1949/ Ex. 1-528). Carpenter and Smyth (1946/Ex. 1-859) reported a no-effect level for diisobutyl ketone of 125 ppm in rats and guinea pigs given 30 seven-hour exposures. At 250 ppm, the liver and kidney weights of female rats increased, and the liver weights of male guinea pigs decreased; at levels of 530 and 920 ppm, rats showed increased liver and kidney weights; and at 1650 ppm, increased mortality was noted (Carpenter and Smyth 1946/Ex. 1-859).
Silverman, Schulte, and First (1946/Ex. 1-142) reported eye irritation and complaints of objectionable odor in volunteer human exposures to concentrations above 25 ppm. No worker illnesses have been linked to diisobutyl ketone exposure (ACGIH 1986/Ex. 1-3, p. 203).
NIOSH (Ex. 150, Comments on Diisobutyl Ketone) concurred with OSHA’s proposal to reduce the limit for diisobutyl ketone and reported that there are no new toxicological data beyond those described above; no other comments on this substance were received. The Agency concludes that the previous 50-ppm TWA limit is inadequate to protect workers against the significant risk of irritation associated with workplace exposures to diisobutyl ketone levels greater than 25 ppm. The Agency has determined that the irritation associated with exposure to diiso- butyl ketone constitutes a material impairment of health and functional capacity. Therefore, OSHA is revising its limit for diisobutyl ketone to 25 ppm as an 8-hour TWA.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue